help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russell, P. S.
Right arrow Articles by Colvin, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russell, P. S.
Right arrow Articles by Colvin, R. B.

American Journal of Pathology, Vol 144, 260-274, Copyright © 1994 by American Society for Investigative Pathology


REGULAR ARTICLES

Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations

PS Russell, CM Chase, HJ Winn and RB Colvin
Department of Surgery, Massachusetts General Hospital, Boston, MA 02114.

An experimental system is described in which coronary arteries of mouse hearts transplanted heterotopically develop obstructive lesions by 4 weeks. Transient immunosuppression permits graft survival. Donor/recipient antigenic differences may be either class I or class II major histocompatibility antigens (H-2) or non-H-2 antigens. An infiltrate including CD4+ and CD8+ T lymphocytes and macrophages concentrates early in the intima and adventitia of larger coronary arteries, with little in the myocardium. Subsequently, the intima expands with cells of donor origin and the infiltrate invades the media. Endothelial and intimal cells express ICAM-1, leukocytes LFA-1: Endothelium expresses class I, but not class II, antigens. As class II disparity alone suffices, the endothelium can apparently be an indirect target of immune injury. We propose that graft atherosclerosis is T cell initiated and elicited by heterogeneous antigens in the endothelium or media. It is separable from rejection of the myocardium.


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Uehara, C. M. Chase, W. H. Kitchens, H. S. Rose, R. B. Colvin, P. S. Russell, and J. C. Madsen
NK Cells Can Trigger Allograft Vasculopathy: The Role of Hybrid Resistance in Solid Organ Allografts
J. Immunol., September 1, 2005; 175(5): 3424 - 3430.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Saiura, M. Sata, K.-i. Hiasa, S. Kitamoto, M. Washida, K. Egashira, R. Nagai, and M. Makuuchi
Antimonocyte Chemoattractant Protein-1 Gene Therapy Attenuates Graft Vasculopathy
Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1886 - 1890.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Furukawa, S. E Cole, R. V Shah, Y. Fukumoto, P. Libby, and R. N Mitchell
Wild-type but not interferon-{gamma}-deficient T cells induce graft arterial disease in the absence of B cells
Cardiovasc Res, August 1, 2004; 63(2): 347 - 356.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. J. Yun, D. Whiting, M. P. Fischbein, A. Banerji, Y. Irie, D. Stein, M. C. Fishbein, A. E.I. Proudfoot, H. Laks, J. A. Berliner, et al.
Combined Blockade of the Chemokine Receptors CCR1 and CCR5 Attenuates Chronic Rejection
Circulation, February 24, 2004; 109(7): 932 - 937.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Vassalli, A. Gallino, M. Weis, W. von Scheidt, L. Kappenberger, L.K. von Segesser, J.-J. Goy, and on behalf of the Working Group Microcirculation of
Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy
Eur. Heart J., July 1, 2003; 24(13): 1180 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Furukawa, P. Libby, J. L. Stinn, G. Becker, and R. N. Mitchell
Cold Ischemia Induces Isograft Arteriopathy, but Does Not Augment Allograft Arteriopathy in Non-Immunosuppressed Hosts
Am. J. Pathol., March 1, 2002; 160(3): 1077 - 1087.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. S. Russell, C. M. Chase, M. Sykes, H. Ito, J. Shaffer, and R. B. Colvin
Tolerance, Mixed Chimerism, and Chronic Transplant Arteriopathy
J. Immunol., November 15, 2001; 167(10): 5731 - 5740.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sata, Z. Luo, and K. Walsh
Fas Ligand Overexpression on Allograft Endothelium Inhibits Inflammatory Cell Infiltration and Transplant-Associated Intimal Hyperplasia
J. Immunol., June 1, 2001; 166(11): 6964 - 6971.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. MAUIYYEDI, P. D. PELLE, S. SAIDMAN, A. B. COLLINS, M. PASCUAL, N. E. TOLKOFF-RUBIN, W. W. WILLIAMS, A. B. COSIMI, E. E. SCHNEEBERGER, and R. B. COLVIN
Chronic Humoral Rejection: Identification of Antibody-Mediated Chronic Renal Allograft Rejection by C4d Deposits in Peritubular Capillaries
J. Am. Soc. Nephrol., March 1, 2001; 12(3): 574 - 582.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
Y. Furukawa, D. A. Mandelbrot, P. Libby, A. H. Sharpe, and R. N. Mitchell
Association of B7-1 Co-Stimulation with the Development of Graft Arterial Disease : Studies Using Mice Lacking B7-1, B7-2, or B7-1/B7-2
Am. J. Pathol., August 1, 2000; 157(2): 473 - 484.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Y. Wang, I. Aronson, S. Takuma, S. Homma, Y. Naka, T. Alshafie, V. Brovkovych, T. Malinski, M. C. Oz, and D. J. Pinsky
cAMP Pulse During Preservation Inhibits the Late Development of Cardiac Isograft and Allograft Vasculopathy
Circ. Res., May 12, 2000; 86(9): 982 - 988.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Yamada, K. Mawulawde, M. T. Menard, A. Shimizu, H. T. Aretz, J. K. Choo, K. S. Allison, J. K. Slisz, D. H. Sachs, and J. C. Madsen
MECHANISMS OF TOLERANCE INDUCTION AND PREVENTION OF CARDIAC ALLOGRAFT VASCULOPATHY IN MINIATURE SWINE: THE EFFECT OF AUGMENTATION OF DONOR ANTIGEN LOAD
J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 709 - 719.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Sata, T. Suhara, and K. Walsh
Vascular Endothelial Cells and Smooth Muscle Cells Differ in Expression of Fas and Fas Ligand and in Sensitivity to Fas Ligand-Induced Cell Death : Implications for Vascular Disease and Therapy
Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 309 - 316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Furukawa, G. Becker, J. L. Stinn, K. Shimizu, P. Libby, and R. N. Mitchell
Interleukin-10 (IL-10) Augments Allograft Arterial Disease : Paradoxical Effects of IL-10 in Vivo
Am. J. Pathol., December 1, 1999; 155(6): 1929 - 1939.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Bian and E. F. Reed
Alloantibody-Mediated Class I Signal Transduction in Endothelial Cells and Smooth Muscle Cells: Enhancement by IFN-{gamma} and TNF-{alpha}
J. Immunol., July 15, 1999; 163(2): 1010 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Friedman, A. Shimizu, R. N. Smith, R. B. Colvin, J. D. Seebach, D. H. Sachs, and J. Iacomini
Human CD4+ T Cells Mediate Rejection of Porcine Xenografts
J. Immunol., May 1, 1999; 162(9): 5256 - 5262.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Hasegawa, G. Becker, H. Nagano, P. Libby, and R. N. Mitchell
Pattern of Graft- and Host-Specific MHC Class II Expression in Long-Term Murine Cardiac Allografts : Origin of Inflammatory and Vascular Wall Cells
Am. J. Pathol., July 1, 1998; 153(1): 69 - 79.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Carmeliet, L. Moons, and D. Collen
Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis
Cardiovasc Res, July 1, 1998; 39(1): 8 - 33.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. A. Jarcho and E. J. Mark
Case 17-1998- A 53-Year-Old Man with Left Ventricular Dysfunction Four Years after a Heart Transplantation
N. Engl. J. Med., May 28, 1998; 338(22): 1608 - 1616.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. S. Allan, J. K. Choo, L. Vesga, J. S. Arn, M. R. Pins, D. H. Sachs, and J. C. Madsen
Cardiac Allograft Vasculopathy Is Abrogated by Anti-CD8 Monoclonal Antibody Therapy
Ann. Thorac. Surg., October 1, 1997; 64(4): 1019 - 1025.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Raisanen-Sokolowski, T. Glysing-Jensen, P. L. Mottram, and M. E Russell
Sustained Anti-CD4/CD8 Treatment Blocks Inflammatory Activation and Intimal Thickening in Mouse Heart Allografts
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2115 - 2122.
[Abstract] [Full Text]


Home page
CirculationHome page
L. H. Chow, S. Huh, J. Jiang, R. Zhong, and J. G. Pickering
Intimal Thickening Develops Without Humoral Immunity in a Mouse Aortic Allograft Model of Chronic Vascular Rejection
Circulation, December 15, 1996; 94(12): 3079 - 3082.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. C. Madsen, D. H. Sachs, J. T. Fallon, and N. J. Weissman
CARDIAC ALLOGRAFT VASCULOPATHY IN PARTIALLY INBRED MINIATURE SWINE. I. TIME COURSE, PATHOLOGY, AND DEPENDENCE ON IMMUNE MECHANISMS
J. Thorac. Cardiovasc. Surg., June 1, 1996; 111(6): 1230 - 1239.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Ardehali, H. Laks, D. C. Drinkwater, E. Ziv, and T. A. Drake
Vascular Cell Adhesion Molecule–1 Is Induced on Vascular Endothelia and Medial Smooth Muscle Cells in Experimental Cardiac Allograft Vasculopathy
Circulation, August 1, 1995; 92(3): 450 - 456.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Hirozane, A. Matsumori, Y. Furukawa, and S. Sasayama
Experimental Graft Coronary Artery Disease in a Murine Heterotopic Cardiac Transplant Model
Circulation, January 15, 1995; 91(2): 386 - 392.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.